Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Fernando Perez-Villatoro"'
Autor:
Jun Dai, Shuyu Zheng, Matías M. Falco, Jie Bao, Johanna Eriksson, Sanna Pikkusaari, Sofia Forstén, Jing Jiang, Wenyu Wang, Luping Gao, Fernando Perez-Villatoro, Olli Dufva, Khalid Saeed, Yinyin Wang, Ali Amiryousefi, Anniina Färkkilä, Satu Mustjoki, Liisa Kauppi, Jing Tang, Anna Vähärautio
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-14 (2024)
Abstract Exploring non-genetic evolution of cell states during cancer treatments has become attainable by recent advances in lineage-tracing methods. However, transcriptional changes that drive cells into resistant fates may be subtle, necessitating
Externí odkaz:
https://doaj.org/article/cb6fd31ba8b2481198015e55a8c83a4c
Autor:
Fernando Perez-Villatoro, Jaana Oikkonen, Julia Casado, Anastasiya Chernenko, Doga C. Gulhan, Manuela Tumiati, Yilin Li, Kari Lavikka, Sakari Hietanen, Johanna Hynninen, Ulla-Maija Haltia, Jaakko S. Tyrmi, Hannele Laivuori, Panagiotis A. Konstantinopoulos, Sampsa Hautaniemi, Liisa Kauppi, Anniina Färkkilä
Publikováno v:
npj Precision Oncology, Vol 6, Iss 1, Pp 1-13 (2022)
Abstract Homologous recombination DNA-repair deficiency (HRD) is a common driver of genomic instability and confers a therapeutic vulnerability in cancer. The accurate detection of somatic allelic imbalances (AIs) has been limited by methods focused
Externí odkaz:
https://doaj.org/article/1510497742624a49b8fc5fba11d6c5dc
Autor:
Sanna Pikkusaari, Manuela Tumiati, Anni Virtanen, Jaana Oikkonen, Yilin Li, Fernando Perez-Villatoro, Taru Muranen, Matilda Salko, Kaisa Huhtinen, Anna Kanerva, Heidi Koskela, Johanna Tapper, Riitta Koivisto-Korander, Titta Joutsiniemi, Ulla-Maija Haltia, Heini Lassus, Sampsa Hautaniemi, Anniina Färkkilä, Johanna Hynninen, Sakari Hietanen, Olli Carpén, Liisa Kauppi
Publikováno v:
Clinical Cancer Research. :OF1-OF14
Purpose: Deficiency in homologous recombination (HR) repair of DNA damage is characteristic of many high-grade serous ovarian cancers (HGSC). It is imperative to identify patients with homologous recombination–deficient (HRD) tumors as they are mos
Autor:
José A Citalán-Jiménez, Carlos A GuizarSanchez, Eduardo Lara-Vazquez, Leonel Martinez-Ramirez, Porfirio Visoso Palacios, Fernando Perez-Villatoro
Publikováno v:
Journal of Cardiology & Current Research. 16:1-5
Introduction: Currently, there is a trend towards non-invasive hemodynamic monitoring guided by echocardiography, however, in our center, in patients undergoing coronary revascularization surgery, invasive hemodynamic monitoring with Swan-Ganz cathet
Autor:
Liisa Kauppi, Olli Carpén, Sakari Hietanen, Johanna Hynninen, Anniina Färkkilä, Sampsa Hautaniemi, Heini Lassus, Ulla-Maija Haltia, Titta Joutsiniemi, Riitta Koivisto-Korander, Johanna Tapper, Heidi Koskela, Anna Kanerva, Kaisa Huhtinen, Matilda Salko, Taru Muranen, Fernando Perez-Villatoro, Yilin Li, Jaana Oikkonen, Anni Virtanen, Manuela Tumiati, Sanna Pikkusaari
Comparison of different fHR score cut-off values.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cf2368cec2030b2f5e654a9ea7cd9ca
https://doi.org/10.1158/1078-0432.22490492
https://doi.org/10.1158/1078-0432.22490492
Autor:
Liisa Kauppi, Olli Carpén, Sakari Hietanen, Johanna Hynninen, Anniina Färkkilä, Sampsa Hautaniemi, Heini Lassus, Ulla-Maija Haltia, Titta Joutsiniemi, Riitta Koivisto-Korander, Johanna Tapper, Heidi Koskela, Anna Kanerva, Kaisa Huhtinen, Matilda Salko, Taru Muranen, Fernando Perez-Villatoro, Yilin Li, Jaana Oikkonen, Anni Virtanen, Manuela Tumiati, Sanna Pikkusaari
Tumor percentages estimated from H&E images and comparison between HR, ovaHRDScar and Telli2016 status.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5165fb84f8b6675c836c0e78cbb3859a
https://doi.org/10.1158/1078-0432.22490483.v1
https://doi.org/10.1158/1078-0432.22490483.v1
Autor:
Liisa Kauppi, Olli Carpén, Sakari Hietanen, Johanna Hynninen, Anniina Färkkilä, Sampsa Hautaniemi, Heini Lassus, Ulla-Maija Haltia, Titta Joutsiniemi, Riitta Koivisto-Korander, Johanna Tapper, Heidi Koskela, Anna Kanerva, Kaisa Huhtinen, Matilda Salko, Taru Muranen, Fernando Perez-Villatoro, Yilin Li, Jaana Oikkonen, Anni Virtanen, Manuela Tumiati, Sanna Pikkusaari
Purpose:Deficiency in homologous recombination (HR) repair of DNA damage is characteristic of many high-grade serous ovarian cancers (HGSC). It is imperative to identify patients with homologous recombination–deficient (HRD) tumors as they are most
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::576b149b8d2a58ae9d5515d1e7fccb01
https://doi.org/10.1158/1078-0432.c.6533165
https://doi.org/10.1158/1078-0432.c.6533165
Autor:
Matilda Salko, Fernando Perez-Villatoro, Jehad Aldahdooh, Anastasiya Chernenko, Elina Pietilä, Ashwini S Nagaraj, Maija Vääriskoski, Heini Lassus, Mikko Loukovaara, Anna Kanerva, Riitta Koivisto-Korander, Johanna Tapper, Jing Tang, Anni Virtanen, Anniina Färkkilä, Ulla-Maija Haltia
Publikováno v:
Ovarian cancer.
Autor:
Jun Dai, Shuyu Zheng, Matías M. Falco, Jie Bao, Johanna Eriksson, Fernando Perez-Villatoro, Anniina Färkkilä, Olli Dufva, Khalid Saeed, Satu Mustjoki, Yinyin Wang, Ali Amiryousefi, Jing Tang, Anna Vähärautio
Exploring non-genetic evolution of cell states during cancer treatments has become attainable by recent advances in lineage-tracing methods coupling cell states to future fates. However, transcriptional changes that drive pre-treatment cells into res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9d634bc825c319232a07ade79d2278b6
https://doi.org/10.1101/2022.07.06.498926
https://doi.org/10.1101/2022.07.06.498926
Autor:
Fernando Perez-Villatoro, Jaana Oikkonen, Julia Casado, Anastasiya Chernenko, Doga C. Gulhan, Manuela Tumiati, Yilin Li, Kari Lavikka, Sakari Hietanen, Johanna Hynninen, Ulla-Maija Haltia, Jaakko S. Tyrmi, Hannele Laivuori, Panagiotis A. Konstantinopoulos, Sampsa Hautaniemi, Liisa Kauppi, Anniina Färkkilä
Homologous recombination DNA-repair deficiency (HRD) is a common driver of genomic instability and confers a therapeutic vulnerability in cancer. The accurate detection of somatic allelic imbalances (AIs) has been limited by methods focused onBRCA1/2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e1cd54f7cea89a7e02467a78e3f77af8
https://doi.org/10.1101/2021.08.19.456809
https://doi.org/10.1101/2021.08.19.456809